Neoadjuvant Therapy is Associated with a Reduced Lymph Node Ratio in Patients with Potentially Resectable Pancreatic Cancer

BACKGROUND: The use of neoadjuvant therapy (NAC) for the treatment of potentially resectable pancreatic cancer remains controversial. In this study we sought to evaluate cancer-specific end-points in patients undergoing a NAC vs. a surgery-first (SF) approach with specific emphasis on lymph node met...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ann Surg Oncol
Autori principali: Roland, Christina L., Yang, Anthony D., Katz, Matthew H. G., Chatterjee, Deyali, Wang, Huamin, Lin, Heather, Vauthey, Jean N., Pisters, Peter W., Varadhachary, Gauri R., Wolff, Robert A., Crane, Christopher H., Lee, Jeffrey E., Fleming, Jason B.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2014
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5131370/
https://ncbi.nlm.nih.gov/pubmed/25352267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-014-4192-6
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi